Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: A prospective randomized clinical trial

Journal of Clinical Oncology

Volumn 22, Issue 15, 2004, Pages 3163-3171

  Hanna, Hend ^a   Benjamin, Robert ^a   Chatzinikolaou, Ioannis ^a   Alakech, Badie ^a   Richardson, Deborah ^a   Mansfield, Paul ^a   Dvorak, Tanya ^a   Munsell, Mark F ^a   Darouiche, Rabih ^a   Kantarjian, Hagop ^a   Raad, Issam ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE; RIFAMPICIN; SILICONE; ANTIINFECTIVE AGENT; SILICONE DERIVATIVE;

ARTICLE; CANCER CENTER; CANCER PATIENT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GRAM POSITIVE COCCI; HUMAN; INFECTION CONTROL; PRIORITY JOURNAL; PROSPECTIVE STUDY; BACTEREMIA; FEMALE; INDWELLING CATHETER; INSTRUMENTATION; MALE; MIDDLE AGED; NEOPLASM; RANDOMIZED CONTROLLED TRIAL;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MINOCYCLINE; NEOPLASMS; PROSPECTIVE STUDIES; RIFAMPIN; SILICONES;

EID: 4143053766     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.04.124     Document Type: Article

References (37)

1. Maki DG: Infections due to infusion therapy, in Bennett JV, Brachman PS (eds): Hospital Infections. Boston, MA, Little Brown, 1992, pp 849-898
2. Pittet D, Tarara D, Wenzel RP: Nosocomial bloodstream infection in critically ill patients: Excess length of stay, extra costs and attributable mortality. JAMA 271:1598-1601, 1994
3. Richards MJ, Edwards JR, Culver DH, et al: Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 21:510-515, 2000
4. Maki DG: Pathogenesis, prevention and management of infections due to intravascular devices for infusion therapy, in Bisno SL, Waldvogel FA (eds): Infections Associated With Indwelling Medical Devices. Washington, DC, American Society for Microbiology, 1989, pp 161-177
5. Raad I, Costerton W, Sabharwal U, et al: Ultrastructural analysis of indwelling vascular catheters: A quantitative relationship between luminal colonization and duration of placement. JID 168:400-407, 1993
6. Watnick R, Kolter R: Biofilm: City of microbes. J Bacteriol 182:2675-2679, 2000
7. Raad I, Darouiche R, Hachem R, et al: The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 173:418-424, 1996
8. Raad II, Hohn DC, Gilbreath BJ, et al: Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 15:231-238, 1994
9. Schwartz C, Henrickson KJ, Roghmann K, et al: Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol 8:1591-1597, 1990
10. Groeger JS, Lucas AB, Thaler HT, et al: Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 119:1168-1174, 1993
11. Mirro J Jr, Rao BN, Kumar M, et al: A comparison of placement techniques and complications of externalized catheters and implantable port use in children with cancer. J Pediatr Surg 25:120-124, 1990
12. Henrickson KJ, Axtell RA, Hoover SM, et al: Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized multicenter, double-blind trial. J Clin Oncol 18:1269-1278, 2000
13. Maki DG, Ringer M, Avarado CJ: Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 338:339-343, 1991
14. Chatzinikolaou I, Zipf TF, Hanna H, et al: Minocycline- ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin Infec Dis 36:116-119, 2003
15. Maki DG, Stolz SM, Wheeler S, et al: Prevention of central venous catheter-related bloodstream infection by use of antiseptic-impregnated catheter: A randomized, controlled trial. Ann Intern Med 127:257-266, 1997
16. Raad I, Darouiche R, Dupuis J, et al: Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: A randomized, double-blind trial - The Texas Medical Center Catheter Study Group. Ann Intern Med 127:267-274, 1997
17. Darouiche RO, Raad II, Heard SO, et al: A comparison of two antimicrobial-impregnated central venous catheters: Catheter Study Group. N Engl J Med 340:1-8, 1999
18. Maki DG, Weise CE, Sarafin HWA: Semi-quantitative culture method for identifying intravenous catheter-related infection. N Engl J Med 296:1305-1309, 1977
19. Sherertz RJ, Raad I, Belani A, et al: Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 28:76-82, 1990
20. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically (ed 5, vol 20, no. 2): Approved standard M7-A5. Wayne, PA, National Committee for Clinical Laboratory Standards, 2000
21. Sherertz RJ, Carruth WA, Hampton AA, et al: Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits. J Infect Dis 167:98-106, 1993
22. Sherertz RJ, Forman DM, Solomon DD: Efficacy of dicloxacillin-coated polyurethane catheters in preventing subcutaneous Staphylococcus aureus infection in mice. Antimicrob Agents Chemother 33:1174-1178, 1989
23. Raad I, Darouiche R, Hachem R, et al: Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother 39:2397-2400, 1995
24. Raad II, Darouiche RO, Hachem R, et al: Antimicrobial durability and rare ultrastructural colonization of indwelling central venous catheters coated with minocycline and rifampin. Crit Care Med 26:219-224, 1998
25. Press OW, Ramsey PG, Larson EB, et al: Hickman catheter infections in patients with malignancies. Medicine 63:189-200, 1984
26. Decker MD, Edwards KM: Central venous catheter infections. Pediatr Clin North Am 35:579-612, 1988
27. Clarke DE, Raffin TA: Infectious complications of indwelling long-term central venous catheters. Chest 97:966-972, 1990
28. Howell PB, Walters PE, Donowitz GR, et al: Risk factors for infection of adult patients with cancer who have tunneled central venous catheters. Cancer 75:1367-1374, 1995
29. O'Grady NP, Alexander M, Dellinger EP, et al: Guidelines for prevention of intravascular catheter-related infections: Centers for Disease Control and Prevention. MMWR Recomm Rep 51:1-29, 2002
30. Logghe C, Van Ossel C, D'Hoore W, et al: Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: A randomized controlled trial. J Hosp Infect 37:145-156, 1997
31. Bassetti S, Hu J, D'agostino RB, et al: Prolonged antimicrobial activity of a catheter containing chlorhexidine-silver sulfadiazine extends protection against catheter infections in vivo. Antimicrob Agents Chemother 45:1535-1538, 2001
32. Nabulsi N, Hanna HA, Raad II: Devices impregnated with novel antiseptic agents: Broad-spectrum activity and prolonged antimicrobial durability. Presented at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, September 22-25, 2001 (abstr K-1459)
33. Rupp ME, Lisco S, Lipsett P, et al: Effect of chlorhexidine/silver sulfadiazine coating on microbial colonization of central venous catheters in a multicenter trial. Presented at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, September 22-25, 2001 (abstr K-2047)
34. Brun-Buisson C, Nitenberg G, Doyon F, et al: Randomized controlled trial of antiseptic-coated (ACC) central venous catheters (CVC). Presented at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, September 27-30, 2002 (abstr K-665)
35. Sampath LA, Tambe SM, Modak SM: In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: Evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infect Control Hosp Epidemiol 22:640-646, 2001
36. Hanna HA, Graviss L, Chaiban G, et al: Susceptibility patterns of Staphylococcal organisms in leukemia and bone marrow transplant (BMT) services after the use of minocycline/rifampin0impregnated central venous catheters (MR-CVC) in a cancer hospital. Presented at the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, September 27-30, 2002 (abstr K-74)
37. Agency for Healthcare Research and Quality: Making health care safer: A critical analysis of patient safety practices. Evidence report/technology assessment, number 43. http://www.ahrq.gov/clinic/epcix.html, July 2001